The estimated Net Worth of Leon Lewkowicz is at least $2.97 Milion dollars as of 16 June 2017. Leon Lewkowicz owns over 71,224 units of Microbot Medical Inc stock worth over $2,855,351 and over the last 7 years Leon sold MBOT stock worth over $118,944.
Leon has made over 1 trades of the Microbot Medical Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Leon sold 71,224 units of MBOT stock worth $118,944 on 16 June 2017.
The largest trade Leon's ever made was selling 71,224 units of Microbot Medical Inc stock on 16 June 2017 worth over $118,944. On average, Leon trades about 71,224 units every 0 days since 2017. As of 16 June 2017 Leon still owns at least 3,078,214 units of Microbot Medical Inc stock.
You can see the complete history of Leon Lewkowicz stock trades at the bottom of the page.
Leon's mailing address filed with the SEC is GORDON STREET 10/7, , TEL-AVIV, L3, 63458.
Over the last 8 years, insiders at Microbot Medical Inc have traded over $5,894,432 worth of Microbot Medical Inc stock and bought 10,000 units worth $11,000 . The most active insiders traders include Yoseph Bornstein, Investment Management Ltd A... oraz Moshe Shoham. On average, Microbot Medical Inc executives and independent directors trade stock every 37 days with the average trade being worth of $46,188. The most recent stock trade was executed by Yoseph Bornstein on 19 October 2020, trading 4,881 units of MBOT stock currently worth $38,755.
microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. through its unique platforms, microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. microbot’s virob platform is an autonomous advancing micro robot (aamr), less then 1mm in diameter, which has the ability to advance (forward/bac
Microbot Medical Inc executives and other stock owners filed with the SEC include: